We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.76%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.13B
AUM Growth
+$508M
Cap. Flow
+$450M
Cap. Flow %
10.89%
Top 10 Hldgs %
28.06%
Holding
5,776
New
587
Increased
2,247
Reduced
2,253
Closed
660

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$135M
2
MSFT icon
Microsoft
MSFT
+$75.2M
3
NVDA icon
NVIDIA
NVDA
+$68.1M
4
AMZN icon
Amazon
AMZN
+$62.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$58.9M

Sector Composition

Rank Sector Weight
1 Technology 29.75%
2 Communication Services 9.71%
3 Consumer Discretionary 9.03%
4 Financials 8.48%
5 Healthcare 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFLI icon
5101
Dragonfly Energy
DFLI
$19.2M
$18 ﹤0.01%
6
-2,019
-100% -$18.5K
APUS
5102
Apimeds Pharmaceuticals US
APUS
$6.47M
$16 ﹤0.01%
+1
New +$21
CRGOW icon
5103
Freightos Ltd Warrant
CRGOW
$1.86M
$14 ﹤0.01%
90
BRLSW icon
5104
Borealis Foods Inc Warrant
BRLSW
$853K
$14 ﹤0.01%
274
NMG
5105
Nouveau Monde Graphite
NMG
$467M
$12 ﹤0.01%
+5
New +$15
DNP icon
5106
DNP Select Income Fund
DNP
$4.1B
$10 ﹤0.01%
1
NAUT icon
5107
Nautilus Biotechnolgy
NAUT
$112M
$10 ﹤0.01%
5
-5,598
-100% -$9.18K
BEX
5108
Tradr 2X Long BE Daily ETF
BEX
$153M
$9 ﹤0.01%
+1
New +$13
AERTW
5109
Aeries Technology Warrant
AERTW
$887K
$6 ﹤0.01%
156
RKLZ
5110
Defiance Daily Target 2x Short RKLB ETF
RKLZ
$2.9M
0
NRXP icon
5111
NRX Pharmaceuticals
NRXP
$146M
$3 ﹤0.01%
1
-323
-100% -$867
HXHX
5112
Haoxin Holdings
HXHX
$6.15M
$1 ﹤0.01%
+2
New +$2
ACRV icon
5113
Acrivon Therapeutics
ACRV
$74.9M
-8,736
Closed -$15.8K
ADAP
5114
DELISTED
Adaptimmune Therapeutics
ADAP
-700
Closed -$91
ADN
5115
DELISTED
Advent Technologies
ADN
-969
Closed -$3.23K
AEMD icon
5116
Aethlon Medical
AEMD
$1.6M
-60
Closed -$2.24K
AFBI
5117
DELISTED
Affinity Bancshares
AFBI
-111
Closed -$2.19K
AFK icon
5118
VanEck Africa Index ETF
AFK
$105M
-3
Closed -$73
AFMC icon
5119
First Trust Active Factor Mid Cap ETF
AFMC
$198M
-31,422
Closed -$1.08M
AFSM icon
5120
First Trust Active Factor Small Cap ETF
AFSM
$122M
-3,823
Closed -$125K
AGG icon
5121
iShares Core US Aggregate Bond ETF
AGG
$137B
-19,607
Closed -$1.97M
AIRE icon
5122
reAlpha
AIRE
$8.32M
-83
Closed -$1.59K
AIVL icon
5123
WisdomTree US AI Enhanced Value Fund
AIVL
$435M
-2,929
Closed -$335K
AKAN icon
5124
Akanda
AKAN
$2.73M
-3
Closed -$279
AKRO
5125
DELISTED
Akero Therapeutics
AKRO
-3,152
Closed -$150K

Similar funds

Tower Research Capital (TRC)'s Q4 2025 Portfolio in Review

As of Q4 2025, Tower Research Capital (TRC) held 5,776 positions worth $4.13B, up 14% from $3.62B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Tower Research Capital (TRC) deployed $450M of net new capital in Q4 2025, opening 587 new positions and adding to 2,247 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 139,132 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 17% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $431M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2025 buy was iShares 20+ Year Treasury Bond ETF: 139,132 shares worth $12.1M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2025, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $431M.
  • Tower Research Capital (TRC) fully exited iShares 0-3 Month Treasury Bond ETF in Q4 2025, selling an estimated $25.1M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 28% of its $4.13B portfolio in Q4 2025.
  • Tower Research Capital (TRC) opened 587 new positions and closed 660 in Q4 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 14% quarter-over-quarter to $4.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.